Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Clinical research and clinical trials

US Loses Measles Elimination Status as PAHO Finds Endemic Transmission Re-established

PAHO announced on 17 November 2026 that the United States, Mexico and Bolivia lost measles elimination status after endemic transmission returned.

Published 18 Nov 2026· Last updated 19 Nov 2026· 5 minute read
The Pan American Health Organization headquarters building in Washington, DC, seen from the street
Photo: ajay_suresh / Wikimedia Commons, CC BY 2.0 (cropped). Source · Licence

The Pan American Health Organization (PAHO) announced on 17 November 2026 that the United States, Mexico and Bolivia have lost their measles elimination status, after its re-verification commission found that endemic transmission had been re-established in all three countries. For the United States, it ends a status held since 2000 and puts surveillance, immunization policy and public health research funding under renewed scrutiny.

What happened

In a 17 November 2026 release, PAHO said its Measles, Rubella and Congenital Rubella Syndrome Elimination Regional Monitoring and Re-Verification Commission (RVC) met on 10-13 November to review the epidemiological situation in the Americas. After the commission’s assessment, whose recommendations were accepted by PAHO Director Dr. Jarbas Barbosa, endemic measles transmission was determined to have been re-established in Bolivia, Mexico and the United States. Under the commission’s criteria, transmission is endemic when the same virus genotype and lineage circulate uninterrupted for 12 months or more.

Barbosa said that “losing measles elimination status is much more than losing a public health designation” because it means the virus has circulated for a prolonged period. He also called it “a serious warning for our Region, but it is not an irreversible setback.”

CIDRAP, the infectious disease research centre at the University of Minnesota, reported that PAHO reached its decision after reviewing epidemiological data from January 2025 through January 2026, a period that predates Pennsylvania’s outbreak, which began in April 2026 and has become the largest in the United States in more than 35 years.

Key details

Item Figure or fact Source
Countries losing status Bolivia, Mexico, United States PAHO
Commission meeting 10-13 November 2026 PAHO
Endemic threshold Same genotype and lineage circulating 12 months or more PAHO
Cases in the Americas to 13 November 2026 58,213 confirmed cases and 82 deaths, versus 12,806 cases in the same period last year PAHO
US confirmed cases in 2026 to 12 November 5,412, about 2.4 times the 2,289 reported in all of 2025 Contagion Live, citing CDC
US school-age MMR coverage, 2025-2026 92.4%, with 39 states below 95% KFF

CIDRAP reported that Pennsylvania has recorded more than 1,500 cases and at least seven measles-associated deaths this year, and that state health departments have reported 13 deaths across 2025 and 2026.

Background and context

PAHO said the Americas was the first region in the world to eliminate measles and regained its regional status in 2024 after Venezuela and Brazil interrupted the transmission that had re-established in 2018 and 2019. The region lost that status again in November 2025 after sustained transmission in Canada. KFF notes that the United States averaged fewer than 150 cases a year between 2000 and 2018 and that national school-age MMR coverage was above 95% when elimination was achieved. It adds that Canada’s epidemic, which began in October 2024, was declared over in October 2026, while the US epidemic continues to accelerate. KFF characterises the loss of status as carrying primarily symbolic weight, because the effect of rising cases and deaths is already clear.

Reaction

CDC director Erica Schwartz said in a statement quoted by CIDRAP that the federal government has invested $100 million in state and local health departments to bring the MMR vaccine to communities with transmission, adding: “Losing a designation doesn’t mean we abandon an evidence-based approach. It means we remain focused on stopping outbreaks.”

Jesse L. Goodman, chair of Georgetown University’s Expert Vaccine Analysis Team and a former FDA chief scientist, called the loss “both a national embarrassment and the tip of a dangerous iceberg.” George Mason University epidemiologist Amira Roess told CIDRAP that surveillance systems “were subjected to significant disruptions, and some of them faced cuts to resources and personnel recently.” Chrissie Juliano, executive director of the Big Cities Health Coalition, said state and local health departments are doing “about as much as humanly possible.”

What it means for researchers, universities and research offices

Surveillance and data partnerships. PAHO’s commission recommends active case finding in health facilities, communities and laboratories every three months with documented results, and genotyping of PCR-positive cases to identify vaccine strains. Roess named routine testing, monitoring of untreated municipal sewage and analysis of emergency department records for fever-and-rash patterns as strategies available to the CDC. University epidemiology and laboratory groups that work with health departments should expect more demand for outbreak data, and research offices will need data-use agreements to keep pace. The CASRAI guide to sentinel surveillance explains one of these approaches.

Academic medical centres and clinical research sites. PAHO’s recommended actions for health workers are to verify vaccination status, enforce institutional immunization policies and apply airborne isolation protocols. Hospital and clinical-trial site managers can compare their current policy with the CASRAI notes on healthcare personnel immunization requirements and outbreak investigation steps in hospitals.

Funding and capacity. CIDRAP and KFF both report that state and local public health departments have faced funding cuts during the current epidemic. Public health researchers who depend on health-department partnerships, and universities whose schools of public health run field programmes, may see shifting priorities as the corrective plan and any new federal investment take shape.

Trust and uptake research. University of Pittsburgh political scientist Miranda Yaver told CIDRAP that restoring resources must go together with broader efforts to rebuild trust in science and government, and that case counts alone are not radically shifting public opinion on MMR vaccines. That points to continued demand for behavioural and communication research on vaccination.

What happens next

CIDRAP reports that the United States is expected to submit a corrective action plan to PAHO in the coming weeks, as are Bolivia and Mexico. PAHO says all three are implementing measures to strengthen vaccination, surveillance and outbreak response, and that Canada has interrupted the chain of transmission linked to its outbreak and is working to regain its status. PAHO’s stated path back to elimination rests on sustaining at least 95% coverage with both doses of the measles vaccine in every community, backed by strong surveillance and effective outbreak response. See also the CASRAI explainer on public health emergencies.

Sources

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →